Healthtech Startups

Kindred provides integrated virtual and in-clinic health services for women, including doctor consultations, counseling, and bundled health management packages for conditions like PCOS, STI, and infertility. The platform operates as a collaborative care model offering comprehensive treatment plans in a judgment-free environment.

3 investors

Kinexcs is an AI-driven digital health company that builds wearables and a platform to support recovery, rehabilitation, and fitness. It serves patients and health enthusiasts aiming to improve mobility and track personalized health goals.

3 investors

Kira Pharmaceuticals is a biotech company developing therapies targeting complement biology to treat complement-mediated diseases. Its work combines drug development and protein engineering, supported by academic collaborators and a scientific advisory board in complement biology and immunology.

3 investors

Kiroku is an AI tool that turns dentists' voice recordings or click-through templates into structured, compliant dental clinical notes, and can also generate patient reports and referral letters. It integrates with cloud-based practice management systems such as Dentally, Dental4Web, and Aerona via a Chrome extension, serving dental practices.

3 investors

Kivo Health provides AI-powered virtual rehabilitation and care programs for patients with chronic obstructive pulmonary disease (COPD), covered by insurance, designed to improve symptoms and reduce hospitalizations.

3 investors

Healthcare company that raised a $24M Series A

3 investors

Klinik Pintar operates a network of standardized clinics in Indonesia and provides clinic management software, pharmaceutical procurement services, and operational support to healthcare facilities.

3 investors

Knit Health AI provides a platform that matches ambulatory patients to appropriate care options across multiple resource types, optimizing utilization based on clinical pathways, patient preferences, and health system capacity. The solution integrates directly into existing health system workflows via APIs to address resource misallocation in healthcare delivery.

3 investors

Kobiolabs (고바이오랩) develops microbiome-based drugs using its Smartiome platform, which applies AI-driven microbiome multi-omics analysis and a microbial library for drug discovery. The company focuses on immune, metabolic, and brain/neurological diseases, and uses a biofoundry-based microbe drug delivery system (mDDS).

3 investors

Koite Health develops patented dual-light technology for dental care and oral health treatments, offering products like Lumoral for both preventive and therapeutic use alongside a subscription tablet line. The company serves dental professionals and consumers in a €20 billion addressable market segment, with expansion potential into mucositis treatment.

3 investors

Korio provides RTSM (Randomization and Trial Supply Management) software for clinical trials, with a focus on experienced project management and continuity throughout the study lifecycle. The company serves clinical operations teams and sponsors managing treatment assignment and supply logistics in regulated pharmaceutical trials.

3 investors

Korro Bio is a biotechnology company developing a new class of RNA-editing therapies guided by human genetics and disease biology. It aims to create genetic medicines for patients with rare and highly prevalent debilitating or life-threatening diseases.

3 investors

Korsana develops technology to deliver large-molecule biologic drugs across the blood-brain barrier using transferrin receptor shuttling, aimed at treating neurodegenerative diseases such as Alzheimer's. Its approach uses antibody engineering to enable therapies with meaningful central nervous system exposure delivered subcutaneously.

3 investors

Kouper builds an AI platform that automates patient-facing healthcare workflows — including appointment scheduling, insurance verification, discharge planning, and care coordination — for healthcare organizations. It aims to improve patient engagement and reduce operational burden for care teams in high-volume clinical environments.

3 investors

Kubanda develops innovative healthcare solutions for pets, focusing on pet wellness.

3 investors

Laminate Medical Technologies develops solutions for arteriovenous fistulas in hemodialysis patients, with a focus on reducing primary fistula failure rates. The company produces VasQ, an external support device designed to improve fistula functionality without requiring additional procedures.

3 investors

Lantern was an end-of-life planning platform providing care plans and planning materials for families. It was acquired by Wellthy and is being decommissioned, with its services integrated into Wellthy's caregiving concierge and planning services.

3 investors

Lasarrus is developing WearME, a multimodal wearable system that continuously monitors six vital signs to detect COPD exacerbations early, giving clinicians up to 48 hours of advance warning. The remote patient monitoring system is aimed at healthcare providers and clinical staff managing patients with chronic obstructive pulmonary disease.

3 investors

Lassie provides software for doctors' offices to automate administrative tasks and office management. The company serves medical practices and is positioned in the healthcare technology sector.

3 investors

LAVA develops the Gammabody platform, which generates bispecific antibodies that activate gamma-delta T cells to treat cancer by directing immune cells to tumors and triggering anti-cancer immune responses.

3 investors

Lavo Life Sciences offers computational molecular simulations to pharmaceutical companies, helping them optimize drug formulations, reduce experimental costs, and accelerate the path to clinical trials and regulatory approval.

3 investors

Layer Health builds AI tools for hospitals and health systems that automate clinical registry abstraction and custom quality-metric extraction across service lines such as cardiovascular, surgery, and oncology. Its platform also supports clinical guidance, including guideline-aligned care pathways and site-of-care optimization by reasoning over the full clinical record.

3 investors

LEAH Labs engineers gene-edited CAR-T cell therapies to treat cancer in pet dogs, with the goal of generating translational insights for human cancer therapy. The company uses proprietary gene editing and protein design to develop therapeutic treatments for companion animal oncology.

3 investors

LemonBox uses artificial intelligence to analyze users' diet, health objectives, and biometric information to create customized daily supplement formulations, which it manufactures and ships monthly as personalized packets. The service targets individuals seeking nutrition tailored to their specific needs.

3 investors